PCOL Lecture PDF
Document Details
Tags
Summary
This document is a lecture on basic principles of pharmacology, covering drug effects, disposition, and clinical uses. It details different classes of drugs, their mechanisms of action, and clinical applications. The lecture also mentions diagnostic agents.
Full Transcript
Ad Random : Ad Aa Aa Ad Ad BASIC PRINCIPLES pharmacology-study of drugs 3 AREAS : BRANCHES what a 1....
Ad Random : Ad Aa Aa Ad Ad BASIC PRINCIPLES pharmacology-study of drugs 3 AREAS : BRANCHES what a 1. Effects of drugs (MOA) Pharmacomicsand do. Fate & 2 Disposition (ADME) Pharmacokinetics. 3 Clinical Uses/Rational Drug Use Pharmacotherapeutics CLASSES OF DRUGS : · Dobutamine (B , selective agonist) 1. Functional Modifiers - ( + ) inotropy (Force : lakas ( - alter biochemical & physiologic activities - (+) chronotropy (HR : bilis)a of the cell - (t) dromotropy (conduction velocity - MAJORITY 4. Chemotherapeutic Agents -must be absent (bacteria viruses, , cancer cells 2. Replenishers #natural/self made - kill/inhibit growth of Foreign cells Fungie which EX ANTI-bacterial , viruses , etc can supplement endogenous cmpds -. are insufficient - Ex. Hypothyroidism : T & To ↳ Tz (Triiodothyronine) - ex more potent us Ta ↳ [p (Tetraiodothyronine/Thyroxine ( ix : Thyroxine -undergoes isomerism "Levo : preparation of choice 4% of levo's activity Dextro : ! Also : Type IDM : binsulin iX : Insulin DI (Diabetes Insipidus) : Avasopressin/ Antidiuretic hormone TX : Vasopressin. 3 Diagnostic Agents For diagnosis - drug alt : - EX : Dobutamine a measure of cardiac ↑ efficiency vs "stress " mechanical. For Pharmacologic Stress Test ↳ (treadmill) (Drug) PHARMACODYNAMICS - effects of drugs (MOA) 2. Regulatory Proteins ? EX (4) drug-body - - :. a. VGICs (Voltage Gated (on Channels) Molecular MOA electrical 1 conduct changes in signals -. ① : Excitatory 11 Interactions. Doug Receptor III. Dose Response Relationships 0 : Inhibitory - CRITERION EXCITATORY INHIBITORY I MOLECULAR MOA.. Cell charge (t) ( ) - key concepts : State Depolarization Hyperpolarization now ? Drug = moA * Effects VGICs that open Nat & Ca+ channels C1- & K + channels Response stimulation &Els Relaxation ↓ CHON X CHON contraction Depression VCHON Protein MON A. : Target Dilation D that BLOCK XGICs > - p Drugs : P = effect Nat channel Blockers i. A X - - Depolarization : RELAXANT structural Regulatory · cell framework/ · maintain cell EX. Class 1 Antiarrhythmics cytoskeleton Functions some Anticonvulsants (Phenytoin Carbamazepine , 1. Structural Protein Local Anesthetics (- caine - Ex Microtubules esters(11) : Procaine (BN). amide (2i) : Lidocaine Xylocaine , a. Biosynthesis Microtubules - ii. K "Channel Blockers polymeri From Tubulins tion ↳ native (functional) miodarone hyperpolarization STIMULANTS Sta - - : ↳ nascent (non-functional) · Mitosis · cell movement EX : Class 11) Antiarrhythmics (EX. Diseases & Insulin Pinsulin release b Drugs secretagogues =. ↓ b sulfonylureas (Climepiride) ↳ I. CA vinca alkaloids (vincristine ( Taxanes (Paclitaxel) Colchicine 1st line acute dougs b Carrier Molecules 2. Inflammation > :. Fungal infection Griseofulvin energy requiring -. 3 - EX : Nat-k Pump (NAP) +. i - ATPase For Caltion extrusion - 2 : - 2 : For Caltion extrusion c. Enzymes ↓ ↳ "lumalabas" - biological catalysts (fastern) For contraction - EX : MAO (Monoamine Oxidase) : ↳ metabolism s of biogenic amines (b) Nat Nat NE , Epi , Dopamine 5 HT- MAOB N N Nat , MAO A ↳ Diseases : · major depression : bNE & 5- HT kt Nat Parkinsonism · : ↓ dopamine Drug : Digoxin Ginotropy - inh NAP = O NCX ↳ Drugs : MAOIs : "Conc. PCa(i) M O PO - For.. For.. X Moclobemide MAO A sel. Phenelzine - ii. Kt-H + -ATPase Pump (Proton Pump socarboxazid I ranylcypromine # on-sel. - parietal cells (stomach) V Selegiline MAOp sel. = HC production (acidic d Receptors Comediators ↑ drugs. ACh Histamine Gastrin interacts via lock & - specific proteins where a ligand key Active site A ①Erg signal transduction - Effect 10 Depolarization/ Hyper 11 20 proton messengers · / pump 1.IIo Phosphorylation Ht No Gene expression gastric Cl- TYPES : lumen # 11 C1- R 1. Type 1 : Conotropic (GICs (Ligand-GICs) Drugs : Proton Pump Inhibitors (PPIs) - cell membrane · - prazole drugs EXCEPT ARPRIPRAZOLE - milliseconds Cantipsychotic effective against hyperacidity Channel ldepolaria > glon · Most on - " ? Ex : "anong channel angkasama EX : most abundant - · ① GABAA : Cl-channels 1 Adrenoceptors (Sympathetic) : a , B ↳ hyperpolarization : INHIBITORY a , O- B , B2 Ga Drugs Conists (supports) Gi Gs Gs ↳ : - > CNS Depressants EX : a, (- Losin) Blockers · Benzodiazepines (- colam , - zepam) ) arteriolar vasodilation ↳ ↑ · Cl-channel Frequency of opening O Barbiturates (-barbital ↳ BP opDuration ② Muscarinic R : Nat channels M , M2 Ms ② Nicotinic R : Ga Gi Ga ↳ depolarization : EXCITATORY EX : -tropium (Ipratropium ↳ Drugs : O Blockers ↳ Ng blocker · Neuromuscular Blockers ↳ Bronchodilator for BA , COPD /Tubocurarine (relaxants skeletal muscles (Kinase-linked 4) ↓ targets. 3 Type III - cell membrane * Type 11 (7-transmembrane/Serpentine/GPCRs/ - min. Metabotropic - EX. Insulin Receptors - cell membrane Growth Factor Rec. - seconds L Epidermal p latelet-derived 0 j /Gene Transcription Linked R/Nuclear / he IV 4. Type - Intracellular R) - nucleus. metabolism Product : ↳ C - his Messenger 4 effects Ligands Lipophilic : - MAJOR EX : a. Steroidal hormones · Mineralocorticoids " Aldosterone - metabolism : Enzymes - · Glucocorticoids - cortisol - o sex hormones Estradiol Adenyly1 Estrogen Phospholipase - C cyclase (AC) (PLC) Progesting Progesterone = 20 msgr : cAMP = 20 msgrs : IPg , DAG Androgens Testosterone # Ca (intral (t) AC (-) AC Gs G; = contraction. b Thyroid Hormones is , is Ga. c Vit D & Vit D derivatives P cAMP ↓ CAMP... B CHON Protein MOA X : Non-Target MECHANISMS (3) : 1. Physical Interactions EX Mannitol. Colligative Mechanism - - Osmotic Diuretic # ↳ Purine excretion (H-0) Osmosis - solvent (H = 0) [fromI solute conc. to P solute conc ]. "pupunta and tubig sa mas matapang na lugar" Urine Kidney tubule blood 00 H,0 mannitol (1) (k) = Aquaresis ↑ S/E Dehydration: Hypovolemia Nat (blood) - conc. = Hypernatremia 2. Chemical Interactions -chemruns a. Neutralization/Acid-Base RX ↳ Antacids (bases) vs. Hyperacidity ↳ Protamine 50p (B) vs. Heparin. Chelation Reaction b ↳ Chelating agents vs Heavy Metals. 3 Counterfeit Mechanism aka drug incorporation - - interfere DNA intermediary metabolism 1 block DNA synthesis Guanine - EX : Antimetabolites A ~ PUrC-Adenine Purine Antagonist Mercaptopurine Thioguanine : , Pyrimidine Antagonist 5-flurouracil Cytarabine : , PyCUT cytosine uracil Thymine # DRUG RECEPTOR INTERACTIONS ② Receptor/Pharmacologic A. Features/Characteristics (Ligand) - eligands same targets opp effects. 1. Affinity ability - to bind - EX : NE vs Propranolol 2. Intrinsic Activity (1A)-ability to activate (+ B, 29)4 B, (-) = Tachycardia : Bradycardia B Classes. (Ligand) 1. Agonist affinity : + 1A Chemical ③ - aka Inactivation Full Partial Inverse - chemryn : RECALL CHEM INT. IA : 1 1A : 30 " IA :< O Heparin (Neutralization , - Ex. Protamine SOp vs · Partial Agonist Deferoxamine vs Fe (Chelation mixed agonist & antagonist effect - COMBINED W/ administered. DOl b (Duration of Interaction ALONE Full Agonist - - EX : key concept : Nalbuphine + Morphine Canalgesic) Y Canalgesic - Partial Agonist - Full Agonist Antago R = howlong ? Whapons - enz : NAT (N-Acetyltransferase ( EX Penicillin vs Probenecid. = reabsorption of Peni (43) - substrates : Hydralazine - saturable Isonian a ide = Michaelis - Mente/zero order) Sulfa drugs. Biliary B. Misc.: 3 sulfation - dominant in neonates - via bile acids > - stool Methylation (COMT) - for high MW dougs ; HIP ex.OralContrast Glycine & Glutamate Conjugation - Limitation : Drug reabsorption via B R.. concept : Whatever happens to bile acids,. ENZYME ALTERATIONS D DRUG FOLLOWS ! D 10 % Excretion : Stool enz Drug - Metabolite. BA 90 % via Biliary Recycling/ Induction Inhibition Reabsorption : · ↑ enz. ↓enz ·. Enterohepatic Recirculation · P met. · ↓ met. C Miscellaneous. Induction Inhibition expired air Drug 1. Lungs - Prodrugs ↑ Active = PE Active = E. 2 Mammary Gland- Milk IA A+ Most common Ex : Tetracyclines PA Toxicity ↑ IA bE C/1 (mottling of teeth) = A IA = : children lactation. 3 Sweat glands - > sweat EX. Rifampicin (red-orange D/C Of sweat AUTONOMIC DRUGS murian Process 2 a. Impulse a Depolarization · I ANATOMY & PHYSIOLOGY (ANS) b Exocytosis.. # Autonomic NS Binding Pr Division : neurons - subdivision of the efferent peripheral NS , · aka Motor Neurons · carry responses (Brain "Effector). d Exocytosis Brain ganglion Effector Post Preganglion -a d · BindingtoPosts ↳ involuntary a ↑ e ganglion · cardiac muscles. (exclusive · smooth muscles CNS · exocrine glands * ANS : 2 motor neurons - salivary O - lacrimal synaptic transmission W/ ganglion - sweat involuntary effectors. subdivisions C (ANS) · Enteric B. Synaptic Neurotransmission · sympathetic 1 parts of Synapse · Parasympathetic sending cell receiving cell - - - YS PARASYMPATHETIC SYMPATHETIC ↓ Anatomy Functions sending Pre-synapse : synthesis storage release S · , , OF NT (vesicle) via Exocytosis (Ca2 + ) A Anatomy (5) Enzymes : Metabolism (ANT) Origin of · 1. Neurons · Autoreceptors : effect is inhibitory S : T , - Ti2 Thoracolumbar NS Cleft - - Enzymes 11 - 15 ~& O - CN 3 , 7 , 9 10 ps : , Craniosacral NS Sz S4 · - receiving : ·S Post-synapse majorityofreceptors - coul e enter 2. Length of Neurons S: - · Enzymes : Metabolism (ANT) short long PS : < E long short 3. Location of Ganglion S : Near the SPINAL CORD PS : Near the EFFECTOR 4. Neurotransmitters II SYMPATHETIC DRUGS. i in catecholamines pre-ganglion Post-ganglion A. Endogenous NE Adrenergic EX. Epi , NE , Dopamine ACh Cholinergic BS Storage "Release Termination True Love Does Not Exist 1. Biosynthesis Receptors (post-synapse Formation of L-DOPA. 5 a. I I Ganglion Effector Enz : Tyrosine hydroxylase (RL enzyme Adrenoceptors (a B) Nicotinis , Cholinoceptors /M N) , Tyrosine L-DOPA (precursor ↑Inhibitor Metyrosine : B. Functional. Formation of DA b 1. General Enz : L-DOPA decarboxylase I Dopamine (1st * Sympha PM L- DOPA cat. ) · NiAdrenergi N stress. Formation c of NE - Fight/Flight - Rest & Digest - inside the vesicle - Enz : Dopamine B-hydroxylase. 2 Specific : Functional Antagonists DA - NE EFFECTOR S PS d. Formation of Epi Heart Tachycardia Bradycardia - adrenal medulla (inner layer) Eyes Mydriasis MiOSIS - En2 : Phenylethanolamine N-methyltransferase (PENMT( Smooth sel Bronchi Bronchodilation Bronchoconstriction muscle 1 GIT lleus/constipation BM/Diarrhea NE Epi Urinary Bladder Urine Retention Urination / Mictuition / (Relaxation - Enuresis (contraction ( (Apocrine /"Ecrine sweating sweating sweat glands : Palms , soles : Generalize : (For Thermoregulation ( 2. storage : VESICIES · Reuptake D major M - NET DA :: via : NE Transporter/Uptake 1 Transporter - - enz ↑ Drugs : Reuptake Inhibitors - YMAT : · PNE binding Agonists = Vesicular Monoamine Transporter Ex Cocaine. Atomoxetine Purpose : To prevent premature Sibutramine metabolism of Dopamine 4 Metabolism. Reserpine : -UMAT 2 inh Enz MAO storage of DA : - · DA catechol-o-methyltransferase (COMT) o · Antagonist - NE , Epi : 3-methoxy-p-hydroxymandelic acid. Release 3 : EXOCYTOSIS laka : Vanilylmandelic acid) Dopa : Homovanillic acid - Enhancers Inhibitors Drugs : - (Agonists (Antagonists). MAOls a : 4 NE binding (Agonists Tyramine i nane the dine Ephedrine Kanadrel EX : MPITS Angio- Amphetamine tensin / , retylium Methamphetamine. COMT Inhibitors b EX : -capone (Entacapone Tolcapone) , 4. Termination - cleft = to remove NE - binding B. ADRENOCEPTORS (a B) , & esynapse Alpha : 1. a : smooth muscles = Contraction Panglalaki - Blood vessels : vasoconstriction = PBP Urine Reuptake - Bladder Trigone & sphincter : Closure = Retention & - Prostate Gland = contraction = Passive abolism - inactive - Radial SM (Iris of the Eyes = contraction Diffusion & = Iris is small ; pupil is big : MYDRIASIS - Pilomotor SM : Piloerection = Goose bumps X Post-synapse systemirelation - Pre-synaptic 2. Az Post-synaptic. a Pre-synaptic : Inhibitory - Autoregulation : inh. NE release I NE binding · · Antisympathetic Sedation Central : " Depression · Exocytosis : Vasodilation DBP Reuptake Inhibition Peripheral : = · : b. Post-synaptic : Excitatory (Gq). 3 Mixed-Acting : DA + 1A (1 Exocytosis) - Blood vessels (Eyes) Vasoconstriction = D) IRECT-ACTING a & B Beta Non-selective sel : MT 1 general type of adrenoceptors I. B, selective : ONLY 1 gen type Heart : Inno] cardiac stimulation one a or B Kidneys (Juxtaglomerular Apparatus : 1. NON-SELECTIVE ↳ renin release Angiotensin I EX. Endogenous Catecholamines (PBP) Epi NE Dopa - , , smooth 2. B2 skeletal pang babae 1 Properties (3) : BB B. 9 Smooth Muscles : Relaxation a. Polar X brain · Bronchi : Bronchodilation - no CNS effects · Uterus : Tocolysis (stay baby !) b. Rapidly inactivated by MAO , CONT · Blood vessels (skeletal Muscles ( - short DOA vasodilation no oral prep IROA : I , SQ inh) = - ,